In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.

In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.

Stent angioplasty provides a minimally invasive treatment for atherosclerotic vessels. However, no treatment option for atherosclerosis-associated endothelial dysfunction, which is accompanied by a loss of CD39, is available, and hence, adverse effects like thromboembolism and restenosis may occur....

Full description

Bibliographic Details
Main Authors: Meike-Kristin Abraham, Andrea Nolte, Rebekka Reus, Andreas Behring, Diane Zengerle, Meltem Avci-Adali, Jan David Hohmann, Karlheinz Peter, Christian Schlensak, Hans Peter Wendel, Stefanie Krajewski
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4575070?pdf=render

Similar Items

Similar Items